Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
6 participants
INTERVENTIONAL
2020-05-29
2023-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ESWT for UE Pain in Patients With Cervical Spinal Cord Injury
NCT04319679
Radial Extracorporeal Shock Wave Therapy on Chronic Low Back Pain: a Prospective Controlled Study
NCT01928784
Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?
NCT01429883
Clinical Utility of ESWT in Restoring Hand Function of Patients With Nerve Injury and Hypertrophic Scars Due to Burns
NCT06438224
Extracorporeal Shock Wave Therapy on Wrist and Hand Functions in Spastic Chronic Stroke Patients
NCT04312581
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
3,000 pulses per time, low energy under 0.3 mJ/mm\^2, tolerable range
Extracorporeal shockwave therapy
Extracorporeal shockwave therapy 6 times during 2 weeks
Control group
Sham therapy
Extracorporeal shockwave therapy
Extracorporeal shockwave therapy 6 times during 2 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Extracorporeal shockwave therapy
Extracorporeal shockwave therapy 6 times during 2 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 1 month after brain damage
* Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS)
* Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE)
* Age: 20 and older
* Person who has agreed in writing to decide his or her participation and comply with the precautions
Exclusion Criteria
* Injection treatments two weeks before participating in the study
* Severe coagulopathy (excluding antiplatelet use)
* Impaired cognition
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bundang CHA Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MinYoung Kim, MD, PhD
Principal professor of Rehabilitation Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MinYoung Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Rehabilitation Medicine, CHA Bundang Medical Center, CHA University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Rehabilitation Medicine, CHA Bundang Medical Center
Seongnam, South Korea, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ESWTbraindamage
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.